Wendy G. Tan

FDA investigator · also recorded as A. Wendy Tan, Ip Wendy Tan

Appears on 11 documents from 2017 to 2023, most often at sites in Singapore. Most often cites control of microbiological contamination (21 CFR 211.113).

11
Documents on file
5.7
Observations per 483
2017
First seen
2023
Most recent

What they cite most

From 63 observations

Activity by year

2017: 2, 2020: 1, 2021: 1, 2022: 2, 2023: 5

Where

Singapore 2 · China 1 · Florida 1 · Germany 1 · Illinois 1 · Indiana 1

Is Wendy G. Tan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Human Genome Sciences, Inc.Dec 11, 2023 · Rockville, Maryland
483 Catalent Indiana, LLCNov 15, 2023 · Bloomington, Indiana
483 Suzhou Union Biopharm Co., Ltd.May 26, 2023 · Suzhou, China
483 Rentschler Biopharma Inc.Mar 22, 2023 · Milford, Massachusetts
483 Rentschler Biopbanna SEMar 7, 2023 · Laupheim, Germany
483 Roche Singapore Technical Operations Pte. Ltd.Aug 1, 2022 · Singapore, Singapore
483 Kashiv BioSciences, LLCJan 14, 2022 · Chicago, Illinois

About this profile

What does Wendy G. Tan inspect?

Wendy G. Tan appears on 11 documents on file covering 11 sites, most often in Singapore.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Wendy G. Tan is dated Dec 11, 2023.